Physician

Maryann M. Shango, MD

According to 2025 Medicare claims, Maryann Shango, MD (NPI: 1942593876) practices internal medicine in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Washington, OR. This provider's primary affiliated billing organization is NORTHWEST CANCER SPECIALISTS PC (NPI: 1407828114; TIN: 931280206) and primary practice location at 97223-8514.

Shango's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 403 traditional Medicare patients, billed 98,955 HCPCS/CPT codes, and received $1,292,104 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,195 prescription claims across 232 beneficiaries totaling $2,046,313 in drug costs, led by Imbruvica (Ibrutinib). Open Payments data shows 2 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,666 to $1,292,104. Similarly, Part D prescription costs have moved sharply higher in recent years, from $78,905 to $2,046,313. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$646K$1.3M2017 Medicare payment: $7,666 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $31,266 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $41,550 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $319,767 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $794,400 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,230,028 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,000,860 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,292,104 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20173192$7,666
2018162519$31,266
2019196696$41,550
202025727,625$319,767
202126967,893$794,400
202241097,516$1,230,028
202339773,233$1,000,860
202440398,955$1,292,104

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.0M2015 Drug cost: $78,905 (USD; Tot_Drug_Cst)2016 Drug cost: $74,544 (USD; Tot_Drug_Cst)2017 Drug cost: $64,544 (USD; Tot_Drug_Cst)2018 Drug cost: $492,216 (USD; Tot_Drug_Cst)2019 Drug cost: $973,393 (USD; Tot_Drug_Cst)2020 Drug cost: $667,449 (USD; Tot_Drug_Cst)2021 Drug cost: $104,814 (USD; Tot_Drug_Cst)2022 Drug cost: $903,809 (USD; Tot_Drug_Cst)2023 Drug cost: $1,664,416 (USD; Tot_Drug_Cst)2024 Drug cost: $2,046,313 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154399$78,905
20164481$74,544
201742114$64,544
201884500$492,216
2019110665$973,393
2020101486$667,449
202179283$104,814
2022191776$903,809
20232281,240$1,664,416
20242321,195$2,046,313

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less79182$109
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more97134$97
80053Blood test, comprehensive group of blood chemicals74264$10
36415Insertion of needle into vein for collection of blood sample82244$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count82292$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib24672$392,770
CalquenceAcalabrutinib Maleate27810$293,327
OrserduElacestrant Hcl11330$245,033
SprycelDasatinib12360$214,405
VerzenioAbemaciclib12336$185,117

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$31PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Maryann M. Shango, MD?

Tedicare shows public-source Medicare data for Maryann M. Shango, MD (NPI 1942593876), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maryann M. Shango, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Maryann M. Shango, MD?

Maryann M. Shango, MD is linked to NORTHWEST CANCER SPECIALISTS PC (billing NPI 1407828114) in the available physician profile data.

Does Maryann M. Shango, MD have Open Payments data?

Maryann M. Shango, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.